Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Renal Denervation to Improve Outcomes in Patients With End-stage Renal

NCT02021019 is registered in ClinicalTrials.gov with Baker Heart and Diabetes Institute as lead sponsor.

NCT NCT02021019
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02021019 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Renal Denervation to Improve Outcomes in Patients With End-stage Renal
Lead sponsor
Baker Heart and Diabetes Institute
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2014
Completion date
December 31, 2022
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end-stage renal disease, hypertension